GlassScriptPhysician profile
James H Tillman
NPI 1164598215
$4,740.31
in general payments reported to CMS, 2019-2025
18 companies · $888 in 2025
The $888 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $626 · 2021: $380 · 2022: $536 · 2023: $736 · 2024: $667 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127 · Entertainment: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.01 |
| Entertainment | $163.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,123.39 | 2019-2025 | Total30, Clareon Panoptix Pro, Rocklatan |
| Kala Pharmaceuticals, INC. | $640.09 | 2019-2021 | |
| Allergan, INC. | $365.07 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $276.41 | 2023-2025 | Miebo, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $241.02 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $236.96 | 2022-2024 | Clarus, Cirrus Hd-Oct |
| Oyster Point Pharma, INC. | $215.47 | 2022-2024 | Tyrvaya |
| Optos, INC. | $203.14 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $89.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $71.27 | 2020-2025 | Cequa |
| Lkc Technologies, INC. | $65.80 | 2025 | |
| Dompe US, INC. | $64.25 | 2024-2025 | Oxervate |
| Abbvie INC. | $33.58 | 2024 | |
| Ocular Therapeutix, INC. | $31.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.95 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $21.88 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Maculogix, INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.